| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2417 | |||||||||||||||||||||||
| Submitter : | Mrs. Maria O'Rourke | Date & Time: | 12/01/2006 08:12:57 | |||||||||||||||||||||
| Organization : | Mrs. Maria O'Rourke | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| Dear FDA,
I am strongly against the use of fetal tissue cell lines for the development of vaccines. Morally acceptable technology is available. Therefore, the use of the aborted fetal cell lines would demonstrate a lack of concern for the moral values of those of us who are concerned for life at every stage of development--whether in the womb or out of it. I will continue to refuse to purchase any vaccine that utilizes aborted fetal cell lines. Sincerely, Maria O'Rourke | ||||||||||||||||||||||||